If you need more lookups,
subscriptions start at $34 USD/month.
Michael Franti Location
Ridgefield, CT, US
Michael Franti Work
Director, Viral Platform (AAVs, Oncolytic Viruses, Lentiviruses) Drug Metabolism and Pharmacokinetics @ (October 2021 - Present)
Director - Head of Regenerative Medicine @ (March 2016 - Present)
Senior Principal Scientist - Project leader Regenerative Medicine @ (January 2013 - March 2016)
Associate Director @ (August 2010 - January 2013)
Head of Molecular Virology @ (March 2008 - August 2010)
Senior Research Investigator @ (July 2006 - March 2008)
Senior staff scientist @ (January 2004 - July 2006)
Research Associate @ (January 2000 - January 2003)
Michael Franti Education
Pierre and Marie Curie University
PhD (Molecular Virology)
1996-2000
Pasteur Institute
(Molecular Virology)
1997-1997
Michael Franti Skills
Preclinical Development
Clinical Trials
Immunoassays
High Throughput Screening
Cell Biology
In Vivo
Hts
Molecular Virology
Antibodies
Assay Development
Biotechnology
Cell
Immunology
Virology
Team Management
Team Leadership
Life Sciences
Healthcare
Strategic Planning
ADME
Strategy
Drug Discovery
Molecular Biology
Lifesciences
Medicine
Microsoft Excel
Clinical Development
Monoclonal Antibodies
In Vitro
Vaccines
Medicinal Chemistry
Project Management
Genetics
Pharmaceutical Industry
Biochemistry
Vaccine
Michael Franti Summary
Michael Franti, based in Ridgefield, CT, US, is currently a Director, Viral Platform (AAVs, Oncolytic Viruses, Lentiviruses) Drug Metabolism and Pharmacokinetics at Boehringer Ingelheim. Michael Franti brings experience from previous roles at Boehringer Ingelheim and Novartis Vaccines and Diagnostics. Michael Franti holds a 1996 - 2000 PhD in Molecular Virology @ Pierre and Marie Curie University. With a robust skill set that includes Preclinical Development, Clinical Trials, Immunoassays, High Throughput Screening, Cell Biology and more. Michael Franti has 2 emails and 3 mobile phone numbers on RocketReach.
Looking for a different Michael Franti?
Find contact details for 700 million professionals.